LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

LLY

1,075.36

-2.69%↓

JNJ

206.6

-0.54%↓

ABBV

227.76

+0.1%↑

UNH

330.04

+0.11%↑

AZN

92.73

-0.69%↓

Home・Aandelen Lijst・Pulse Biosciences Inc

Pulse Biosciences Inc

Gesloten

SectorGezondheidszorg

13.7 -0.44

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

13.56

Max

13.79

Belangrijke statistieken
By Trading Economics
Inkomsten	-217K -19M
Verkoop	86K 86K
EPS	-0.29
Winstmarge	-22,540.698
Werknemers	75
EBITDA	-228K -19M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+59.54% upside

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-179M 958M
Vorige openingsprijs	14.14
Vorige sluitingsprijs	13.7

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

16.59 / 17.17 Steun & Weerstand

Pulse Biosciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

28 nov 2025, 15:29 UTC

Belangrijke Marktbewegers

Acquisities, Fusies, Overnames

China's Jiangxi Copper Rejected by SolGold in $1 Billion Takeover Approach

28 nov 2025, 21:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

28 nov 2025, 19:59 UTC

Marktinformatie

Oil Futures Settle Lower in Slow Black Friday Trade -- Market Talk

28 nov 2025, 19:47 UTC

Marktinformatie

U.S. Natural Gas Lifted By Cold Weather Outlook -- Market Talk

28 nov 2025, 18:16 UTC

Marktinformatie

Global Equities Roundup: Market Talk

28 nov 2025, 18:16 UTC

Marktinformatie

Messy Canada GDP Data Still Seen as Cause for Optimism in 2026 -- Market Talk

28 nov 2025, 18:08 UTC

Marktinformatie

Market Talk Roundup: Latest on U.S. Politics

28 nov 2025, 18:08 UTC

Marktinformatie

Messy Canada GDP Data Still Seen as Cause for Optimism in 2026 -- Market Talk

28 nov 2025, 17:48 UTC

Marktinformatie

Bank of Canada May Revise Up Inflation Projections After GDP Data -- Market Talk

28 nov 2025, 17:20 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

28 nov 2025, 16:50 UTC

Acquisities, Fusies, Overnames

Week's Best: Sieg's Stature at Citi Grows -- Barrons.com

28 nov 2025, 15:51 UTC

Marktinformatie

Canada Household Spending Edges Lower -- Market Talk

28 nov 2025, 15:33 UTC

Marktinformatie

Crude Futures Gain as U.S. Market Reopens -- Market Talk

28 nov 2025, 15:21 UTC

Marktinformatie

Gold Rises on U.S. Rate-Cut Bets After CME Outage -- Market Talk

28 nov 2025, 15:13 UTC

Marktinformatie

Dollar Recovers Slightly as Investors Already Price in Fed Rate Cut -- Market Talk

28 nov 2025, 15:11 UTC

Marktinformatie

Global Equities Roundup: Market Talk

28 nov 2025, 15:11 UTC

Marktinformatie

Canadian National Railway Showing Positive Trend Going Into 2026 -- Market Talk

28 nov 2025, 14:51 UTC

Marktinformatie

Canada GDP Report Masks Fragile State of Economy -- Market Talk

28 nov 2025, 14:41 UTC

Marktinformatie

Canada's GDP Level Pulled Higher by 'Eye-Opening' Revisions -- Market Talk

28 nov 2025, 14:37 UTC

Marktinformatie

U.S. Natural Gas Futures Rise As Temperatures Drop -- Market Talk

28 nov 2025, 14:33 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

28 nov 2025, 14:33 UTC

Marktinformatie

Steep Import Drop Fuels Surprise Lift in Canada GDP -- Market Talk

28 nov 2025, 14:20 UTC

Marktinformatie

Too Much Noise in Canada's Surprise 3Q GDP Gain -- Market Talk

28 nov 2025, 14:10 UTC

Marktinformatie

Canadian Nowcast Came Closest to Predicting Surprise 3Q Strength -- Market Talk

28 nov 2025, 13:39 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

28 nov 2025, 13:39 UTC

Marktinformatie

Canada Trade Data Could Face Larger-Than-Normal Revisions -- Market Talk

28 nov 2025, 13:36 UTC

Marktinformatie

Canada's Economy Expands More Than Expected -- Market Talk

28 nov 2025, 13:29 UTC

Marktinformatie

CME Outage Sowing Chaos Across Markets, Trade Nations Says -- Market Talk

28 nov 2025, 13:27 UTC

Marktinformatie

Russia-Ukraine Peace Efforts to Have Little Impact on Oil Fundamentals -- Market Talk

28 nov 2025, 13:19 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

Peer Vergelijking

Prijswijziging

Pulse Biosciences Inc Prognose

Koersdoel

By TipRanks

59.54% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 22 USD 59.54%

Hoogste 22 USD

Laagste 22 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Pulse Biosciences Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Gebaseerd op 1 analisten die aandelenratings hebben gegeven aan Pulse Biosciences Inc - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

16.59 / 17.17Steun & Weerstand

Recent bearish events outweigh bullish events.

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.